Clinical Trial Update: Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing balsalazide disodium to mesalamine in mildly to moderately active ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BALSALAZIDE DISODIUM (balsalazide disodium)
• Mesalamine (Mesalamine)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Inflammatory Bowel Disease, Ulcerative Colitis | Phase 3 | Status: COMPLETED